Non-Hodgkin's lymphoma vaccine (XEME Biopharma)

N/A

Report date: 2023/05/05 17:38:39

Base Information

Drug NameNon-Hodgkin's lymphoma vaccine (XEME Biopharma)

Drug Alias NameOncoquest-L vaccine非何杰金淋巴瘤疫苗 - XEME BiopharmaB-cell lymphoma vaccine (XEME Biopharma)非霍奇金淋巴瘤的疫苗 - XEME BiopharmaFollicular lymphoma vaccine +[6]

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionNatural killer cells stimulantsCytotoxic T lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsLymphoma, Follicular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesXeme Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesXeme Biopharma Inc

Inactive CompaniesN/A

Active IndicationsLymphoma, Follicular

Inactive IndicationsN/A

Other Information

ATC CodeN/A